APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Levornidazole API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Levornidazole API Market Analysis and Forecast 2026-2032

Report ID 173298680229 December 2025199 pages

Choose your research edition.

Industry ResearchLevornidazole API Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Levornidazole API Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Levornidazole API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Levornidazole API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Levornidazole API Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Levornidazole API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Levornidazole API's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Hebei Guangxiang Pharmaceutical as the global sales leader, a title it has maintained for several consecutive years. Notably, Hebei Guangxiang Pharmaceutical's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Levornidazole API market include Hebei Guangxiang Pharmaceutical, Zhejiang Supor Pharmaceuticals, Nanjing Sanhome Pharmaceutical and Hunan Warrant Chiral Pharmaceutical, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Levornidazole API production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Levornidazole API by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Levornidazole API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Levornidazole API, also provides the consumption of main regions and countries. Of the upcoming market potential for Levornidazole API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Levornidazole API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Levornidazole API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Levornidazole API sales, projected growth trends, production technology, application and end-user industry.

Levornidazole API Segment by Company

Hebei Guangxiang Pharmaceutical

Zhejiang Supor Pharmaceuticals

Nanjing Sanhome Pharmaceutical

Hunan Warrant Chiral Pharmaceutical

Levornidazole API Segment by Type

Purity≥99%

Purity<99%

Levornidazole API Segment by Application

Tablets

Injection

Capsules

Levornidazole API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levornidazole API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Levornidazole API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levornidazole API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Levornidazole API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Levornidazole API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Levornidazole API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Levornidazole API sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Levornidazole API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity≥99% Major Manufacturers Table 3. Purity<99% Major Manufacturers Table 4. Global Levornidazole API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Tablets Major Manufacturers Table 6. Injection Major Manufacturers Table 7. Capsules Major Manufacturers Table 8. Levornidazole API Industry Trends Table 9. Levornidazole API Industry Drivers Table 10. Levornidazole API Industry Opportunities and Challenges Table 11. Levornidazole API Industry Restraints Table 12. Global Levornidazole API Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 13. Global Levornidazole API Production by Region (2021-2026) & (Tons) Table 14. Global Levornidazole API Production by Region (2027-2032) & (Tons) Table 15. Global Levornidazole API Production Market Share by Region (2021-2026) Table 16. Global Levornidazole API Production Market Share by Region (2027-2032) Table 17. Global Levornidazole API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Levornidazole API Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Levornidazole API Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Levornidazole API Revenue Market Share by Region (2021-2026) Table 21. Global Levornidazole API Revenue Market Share by Region (2027-2032) Table 22. Global Levornidazole API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 23. Global Levornidazole API Sales by Region (2021-2026) & (Tons) Table 24. Global Levornidazole API Sales by Region (2027-2032) & (Tons) Table 25. Global Levornidazole API Sales Market Share by Region (2021-2026) Table 26. Global Levornidazole API Sales Market Share by Region (2027-2032) Table 27. Global Levornidazole API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Levornidazole API Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Levornidazole API Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Levornidazole API Sales Market Share by Manufacturers (2021-2026) Table 31. Global Levornidazole API Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 32. Global Levornidazole API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Levornidazole API Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Levornidazole API Manufacturers, Product Type & Application Table 35. Global Levornidazole API Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Levornidazole API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Levornidazole API Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Levornidazole API Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Levornidazole API Revenue Market Share by Type (2021-2026) Table 41. Global Levornidazole API Revenue Market Share by Type (2027-2032) Table 42. Global Levornidazole API Sales by Type (2021-2026) & (Tons) Table 43. Global Levornidazole API Sales by Type (2027-2032) & (Tons) Table 44. Global Levornidazole API Sales Market Share by Type (2021-2026) Table 45. Global Levornidazole API Sales Market Share by Type (2027-2032) Table 46. Global Levornidazole API Price by Type (2021-2026) & (US$/Ton) Table 47. Global Levornidazole API Price by Type (2027-2032) & (US$/Ton) Table 48. Global Levornidazole API Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Levornidazole API Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Levornidazole API Revenue Market Share by Application (2021-2026) Table 51. Global Levornidazole API Revenue Market Share by Application (2027-2032) Table 52. Global Levornidazole API Sales by Application (2021-2026) & (Tons) Table 53. Global Levornidazole API Sales by Application (2027-2032) & (Tons) Table 54. Global Levornidazole API Sales Market Share by Application (2021-2026) Table 55. Global Levornidazole API Sales Market Share by Application (2027-2032) Table 56. Global Levornidazole API Price by Application (2021-2026) & (US$/Ton) Table 57. Global Levornidazole API Price by Application (2027-2032) & (US$/Ton) Table 58. Hebei Guangxiang Pharmaceutical Company Information Table 59. Hebei Guangxiang Pharmaceutical Business Overview Table 60. Hebei Guangxiang Pharmaceutical Levornidazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Hebei Guangxiang Pharmaceutical Levornidazole API Product Portfolio Table 62. Hebei Guangxiang Pharmaceutical Recent Development Table 63. Zhejiang Supor Pharmaceuticals Company Information Table 64. Zhejiang Supor Pharmaceuticals Business Overview Table 65. Zhejiang Supor Pharmaceuticals Levornidazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Zhejiang Supor Pharmaceuticals Levornidazole API Product Portfolio Table 67. Zhejiang Supor Pharmaceuticals Recent Development Table 68. Nanjing Sanhome Pharmaceutical Company Information Table 69. Nanjing Sanhome Pharmaceutical Business Overview Table 70. Nanjing Sanhome Pharmaceutical Levornidazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Nanjing Sanhome Pharmaceutical Levornidazole API Product Portfolio Table 72. Nanjing Sanhome Pharmaceutical Recent Development Table 73. Hunan Warrant Chiral Pharmaceutical Company Information Table 74. Hunan Warrant Chiral Pharmaceutical Business Overview Table 75. Hunan Warrant Chiral Pharmaceutical Levornidazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Hunan Warrant Chiral Pharmaceutical Levornidazole API Product Portfolio Table 77. Hunan Warrant Chiral Pharmaceutical Recent Development Table 78. North America Levornidazole API Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Levornidazole API Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Levornidazole API Sales by Type (2021-2026) & (Tons) Table 81. North America Levornidazole API Sales by Type (2027-2032) & (Tons) Table 82. North America Levornidazole API Sales Price by Type (2021-2026) & (US$/Ton) Table 83. North America Levornidazole API Sales Price by Type (2027-2032) & (US$/Ton) Table 84. North America Levornidazole API Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Levornidazole API Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Levornidazole API Sales by Application (2021-2026) & (Tons) Table 87. North America Levornidazole API Sales by Application (2027-2032) & (Tons) Table 88. North America Levornidazole API Sales Price by Application (2021-2026) & (US$/Ton) Table 89. North America Levornidazole API Sales Price by Application (2027-2032) & (US$/Ton) Table 90. North America Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Levornidazole API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Levornidazole API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Levornidazole API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 94. North America Levornidazole API Sales by Country (2021-2026) & (Tons) Table 95. North America Levornidazole API Sales by Country (2027-2032) & (Tons) Table 96. North America Levornidazole API Sales Price by Country (2021-2026) & (US$/Ton) Table 97. North America Levornidazole API Sales Price by Country (2027-2032) & (US$/Ton) Table 98. United States Levornidazole API Revenue (2021-2032) & (US$ Million) Table 99. Canada Levornidazole API Revenue (2021-2032) & (US$ Million) Table 100. Mexico Levornidazole API Revenue (2021-2032) & (US$ Million) Table 101. Europe Levornidazole API Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Levornidazole API Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Levornidazole API Sales by Type (2021-2026) & (Tons) Table 104. Europe Levornidazole API Sales by Type (2027-2032) & (Tons) Table 105. Europe Levornidazole API Sales Price by Type (2021-2026) & (US$/Ton) Table 106. Europe Levornidazole API Sales Price by Type (2027-2032) & (US$/Ton) Table 107. Europe Levornidazole API Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Levornidazole API Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Levornidazole API Sales by Application (2021-2026) & (Tons) Table 110. Europe Levornidazole API Sales by Application (2027-2032) & (Tons) Table 111. Europe Levornidazole API Sales Price by Application (2021-2026) & (US$/Ton) Table 112. Europe Levornidazole API Sales Price by Application (2027-2032) & (US$/Ton) Table 113. Europe Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Levornidazole API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Levornidazole API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Levornidazole API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 117. Europe Levornidazole API Sales by Country (2021-2026) & (Tons) Table 118. Europe Levornidazole API Sales by Country (2027-2032) & (Tons) Table 119. Europe Levornidazole API Sales Price by Country (2021-2026) & (US$/Ton) Table 120. Europe Levornidazole API Sales Price by Country (2027-2032) & (US$/Ton) Table 121. Germany Levornidazole API Revenue (2021-2032) & (US$ Million) Table 122. France Levornidazole API Revenue (2021-2032) & (US$ Million) Table 123. U.K. Levornidazole API Revenue (2021-2032) & (US$ Million) Table 124. Italy Levornidazole API Revenue (2021-2032) & (US$ Million) Table 125. Russia Levornidazole API Revenue (2021-2032) & (US$ Million) Table 126. Spain Levornidazole API Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Levornidazole API Revenue (2021-2032) & (US$ Million) Table 128. Switzerland Levornidazole API Revenue (2021-2032) & (US$ Million) Table 129. Sweden Levornidazole API Revenue (2021-2032) & (US$ Million) Table 130. Poland Levornidazole API Revenue (2021-2032) & (US$ Million) Table 131. China Levornidazole API Revenue by Type (2021-2026) & (US$ Million) Table 132. China Levornidazole API Revenue by Type (2027-2032) & (US$ Million) Table 133. China Levornidazole API Sales by Type (2021-2026) & (Tons) Table 134. China Levornidazole API Sales by Type (2027-2032) & (Tons) Table 135. China Levornidazole API Sales Price by Type (2021-2026) & (US$/Ton) Table 136. China Levornidazole API Sales Price by Type (2027-2032) & (US$/Ton) Table 137. China Levornidazole API Revenue by Application (2021-2026) & (US$ Million) Table 138. China Levornidazole API Revenue by Application (2027-2032) & (US$ Million) Table 139. China Levornidazole API Sales by Application (2021-2026) & (Tons) Table 140. China Levornidazole API Sales by Application (2027-2032) & (Tons) Table 141. China Levornidazole API Sales Price by Application (2021-2026) & (US$/Ton) Table 142. China Levornidazole API Sales Price by Application (2027-2032) & (US$/Ton) Table 143. Asia Levornidazole API Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Levornidazole API Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Levornidazole API Sales by Type (2021-2026) & (Tons) Table 146. Asia Levornidazole API Sales by Type (2027-2032) & (Tons) Table 147. Asia Levornidazole API Sales Price by Type (2021-2026) & (US$/Ton) Table 148. Asia Levornidazole API Sales Price by Type (2027-2032) & (US$/Ton) Table 149. Asia Levornidazole API Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Levornidazole API Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Levornidazole API Sales by Application (2021-2026) & (Tons) Table 152. Asia Levornidazole API Sales by Application (2027-2032) & (Tons) Table 153. Asia Levornidazole API Sales Price by Application (2021-2026) & (US$/Ton) Table 154. Asia Levornidazole API Sales Price by Application (2027-2032) & (US$/Ton) Table 155. Asia Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Levornidazole API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Levornidazole API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Levornidazole API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 159. Asia Levornidazole API Sales by Country (2021-2026) & (Tons) Table 160. Asia Levornidazole API Sales by Country (2027-2032) & (Tons) Table 161. Asia Levornidazole API Sales Price by Country (2021-2026) & (US$/Ton) Table 162. Asia Levornidazole API Sales Price by Country (2027-2032) & (US$/Ton) Table 163. Japan Levornidazole API Revenue (2021-2032) & (US$ Million) Table 164. South Korea Levornidazole API Revenue (2021-2032) & (US$ Million) Table 165. India Levornidazole API Revenue (2021-2032) & (US$ Million) Table 166. Australia Levornidazole API Revenue (2021-2032) & (US$ Million) Table 167. Taiwan Levornidazole API Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Levornidazole API Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Levornidazole API Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Levornidazole API Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Levornidazole API Sales by Type (2021-2026) & (Tons) Table 172. SAMEA Levornidazole API Sales by Type (2027-2032) & (Tons) Table 173. SAMEA Levornidazole API Sales Price by Type (2021-2026) & (US$/Ton) Table 174. SAMEA Levornidazole API Sales Price by Type (2027-2032) & (US$/Ton) Table 175. SAMEA Levornidazole API Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Levornidazole API Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Levornidazole API Sales by Application (2021-2026) & (Tons) Table 178. SAMEA Levornidazole API Sales by Application (2027-2032) & (Tons) Table 179. SAMEA Levornidazole API Sales Price by Application (2021-2026) & (US$/Ton) Table 180. SAMEA Levornidazole API Sales Price by Application (2027-2032) & (US$/Ton) Table 181. SAMEA Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Levornidazole API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Levornidazole API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Levornidazole API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 185. SAMEA Levornidazole API Sales by Country (2021-2026) & (Tons) Table 186. SAMEA Levornidazole API Sales by Country (2027-2032) & (Tons) Table 187. SAMEA Levornidazole API Sales Price by Country (2021-2026) & (US$/Ton) Table 188. SAMEA Levornidazole API Sales Price by Country (2027-2032) & (US$/Ton) Table 189. Brazil Levornidazole API Revenue (2021-2032) & (US$ Million) Table 190. Argentina Levornidazole API Revenue (2021-2032) & (US$ Million) Table 191. Chile Levornidazole API Revenue (2021-2032) & (US$ Million) Table 192. Colombia Levornidazole API Revenue (2021-2032) & (US$ Million) Table 193. Peru Levornidazole API Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Levornidazole API Revenue (2021-2032) & (US$ Million) Table 195. Israel Levornidazole API Revenue (2021-2032) & (US$ Million) Table 196. UAE Levornidazole API Revenue (2021-2032) & (US$ Million) Table 197. Turkey Levornidazole API Revenue (2021-2032) & (US$ Million) Table 198. Iran Levornidazole API Revenue (2021-2032) & (US$ Million) Table 199. Egypt Levornidazole API Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Levornidazole API Distributors List Table 203. Levornidazole API Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Levornidazole API Product Image Figure 2. Global Levornidazole API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levornidazole API Market Size Share 2021 VS 2025 VS 2032 Figure . Purity≥99% Image Figure 1. Purity<99% Image Figure 2. Global Levornidazole API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levornidazole API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Injection Image Figure 6. Capsules Image Figure 7. Global Levornidazole API Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 8. Global Levornidazole API Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 9. Global Levornidazole API Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Levornidazole API Production Market Share by Region (2021-2032) Figure 11. North America Levornidazole API Production Growth Rate (2021-2032) & (Tons) Figure 12. Europe Levornidazole API Production Growth Rate (2021-2032) & (Tons) Figure 13. China Levornidazole API Production Growth Rate (2021-2032) & (Tons) Figure 14. Japan Levornidazole API Production Growth Rate (2021-2032) & (Tons) Figure 15. Global Levornidazole API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Levornidazole API Revenue (2021-2032) & (US$ Million) Figure 17. Global Levornidazole API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Levornidazole API Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Levornidazole API Revenue Market Share by Region (2021-2032) Figure 20. Global Levornidazole API Sales (2021-2032) & (Tons) Figure 21. Global Levornidazole API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 22. Global Levornidazole API Sales Market Share by Region (2021-2032) Figure 23. North America Levornidazole API Sales YoY (2021-2032) & (Tons) Figure 24. Europe Levornidazole API Sales YoY (2021-2032) & (Tons) Figure 25. China Levornidazole API Sales YoY (2021-2032) & (Tons) Figure 26. Asia (Excluding China) Levornidazole API Sales YoY (2021-2032) & (Tons) Figure 27. South America, Middle East and Africa Levornidazole API Sales YoY (2021-2032) & (Tons) Figure 28. Global Levornidazole API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Levornidazole API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Levornidazole API Revenue Market Share by Type (2021-2032) Figure 32. Global Levornidazole API Sales Market Share by Type (2021-2032) Figure 33. Global Levornidazole API Revenue Market Share by Application (2021-2032) Figure 34. Global Levornidazole API Sales Market Share by Application (2021-2032) Figure 35. North America Levornidazole API Revenue Share by Type (2021-2032) Figure 36. North America Levornidazole API Sales Share by Type (2021-2032) Figure 37. North America Levornidazole API Revenue Share by Application (2021-2032) Figure 38. North America Levornidazole API Sales Share by Application (2021-2032) Figure 39. North America Levornidazole API Revenue Share by Country (2021-2032) Figure 40. North America Levornidazole API Sales Share by Country (2021-2032) Figure 41. Europe Levornidazole API Revenue Share by Type (2021-2032) Figure 42. Europe Levornidazole API Sales Share by Type (2021-2032) Figure 43. Europe Levornidazole API Revenue Share by Application (2021-2032) Figure 44. Europe Levornidazole API Sales Share by Application (2021-2032) Figure 45. Europe Levornidazole API Revenue Share by Country (2021-2032) Figure 46. Europe Levornidazole API Sales Share by Country (2021-2032) Figure 47. China Levornidazole API Revenue Share by Type (2021-2032) Figure 48. China Levornidazole API Sales Share by Type (2021-2032) Figure 49. China Levornidazole API Revenue Share by Application (2021-2032) Figure 50. China Levornidazole API Sales Share by Application (2021-2032) Figure 51. Asia Levornidazole API Revenue Share by Type (2021-2032) Figure 52. Asia Levornidazole API Sales Share by Type (2021-2032) Figure 53. Asia Levornidazole API Revenue Share by Application (2021-2032) Figure 54. Asia Levornidazole API Sales Share by Application (2021-2032) Figure 55. Asia Levornidazole API Revenue Share by Country (2021-2032) Figure 56. Asia Levornidazole API Sales Share by Country (2021-2032) Figure 57. SAMEA Levornidazole API Revenue Share by Type (2021-2032) Figure 58. SAMEA Levornidazole API Sales Share by Type (2021-2032) Figure 59. SAMEA Levornidazole API Revenue Share by Application (2021-2032) Figure 60. SAMEA Levornidazole API Sales Share by Application (2021-2032) Figure 61. SAMEA Levornidazole API Revenue Share by Country (2021-2032) Figure 62. SAMEA Levornidazole API Sales Share by Country (2021-2032) Figure 63. Levornidazole API Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Levornidazole API Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥99%
  • Purity<99%
Applications
  • Tablets
  • Injection
  • Capsules
Companies covered
  • Hebei Guangxiang Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Nanjing Sanhome Pharmaceutical
  • Hunan Warrant Chiral Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Levornidazole API Market by Type
  3. 1.2.1 Global Levornidazole API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity≥99%
  5. 1.2.3 Purity<99%
  6. 1.3 Levornidazole API Market by Application
  7. 1.3.1 Global Levornidazole API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Tablets
  9. 1.3.3 Injection
  10. 1.3.4 Capsules
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Levornidazole API Market Dynamics
  1. 2.1 Levornidazole API Industry Trends
  2. 2.2 Levornidazole API Industry Drivers
  3. 2.3 Levornidazole API Industry Opportunities and Challenges
  4. 2.4 Levornidazole API Industry Restraints
3 Global Levornidazole API Production Overview
  1. 3.1 Global Levornidazole API Production Capacity (2021-2032)
  2. 3.2 Global Levornidazole API Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Levornidazole API Production by Region
  4. 3.3.1 Global Levornidazole API Production by Region (2021-2026)
  5. 3.3.2 Global Levornidazole API Production by Region (2027-2032)
  6. 3.3.3 Global Levornidazole API Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Levornidazole API Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Levornidazole API Revenue by Region
  3. 4.2.1 Global Levornidazole API Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Levornidazole API Revenue by Region (2021-2026)
  5. 4.2.3 Global Levornidazole API Revenue by Region (2027-2032)
  6. 4.2.4 Global Levornidazole API Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Levornidazole API Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Levornidazole API Sales by Region
  9. 4.4.1 Global Levornidazole API Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Levornidazole API Sales by Region (2021-2026)
  11. 4.4.3 Global Levornidazole API Sales by Region (2027-2032)
  12. 4.4.4 Global Levornidazole API Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Levornidazole API Revenue by Manufacturers
  2. 5.1.1 Global Levornidazole API Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Levornidazole API Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Levornidazole API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Levornidazole API Sales by Manufacturers
  6. 5.2.1 Global Levornidazole API Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Levornidazole API Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Levornidazole API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Levornidazole API Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Levornidazole API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Levornidazole API Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Levornidazole API Manufacturers, Product Type & Application
  13. 5.7 Global Levornidazole API Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Levornidazole API Market CR5 and HHI
  16. 5.8.2 2025 Levornidazole API Tier 1, Tier 2, and Tier 3
6 Levornidazole API Market by Type
  1. 6.1 Global Levornidazole API Revenue by Type
  2. 6.1.1 Global Levornidazole API Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Levornidazole API Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Levornidazole API Sales by Type
  5. 6.2.1 Global Levornidazole API Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Levornidazole API Sales Market Share by Type (2021-2032)
  7. 6.3 Global Levornidazole API Price by Type
7 Levornidazole API Market by Application
  1. 7.1 Global Levornidazole API Revenue by Application
  2. 7.1.1 Global Levornidazole API Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Levornidazole API Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Levornidazole API Sales by Application
  5. 7.2.1 Global Levornidazole API Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Levornidazole API Sales Market Share by Application (2021-2032)
  7. 7.3 Global Levornidazole API Price by Application
8 Company Profiles
  1. 8.1 Hebei Guangxiang Pharmaceutical
  2. 8.1.1 Hebei Guangxiang Pharmaceutical Company Information
  3. 8.1.2 Hebei Guangxiang Pharmaceutical Business Overview
  4. 8.1.3 Hebei Guangxiang Pharmaceutical Levornidazole API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Hebei Guangxiang Pharmaceutical Levornidazole API Product Portfolio
  6. 8.1.5 Hebei Guangxiang Pharmaceutical Recent Developments
  7. 8.2 Zhejiang Supor Pharmaceuticals
  8. 8.2.1 Zhejiang Supor Pharmaceuticals Company Information
  9. 8.2.2 Zhejiang Supor Pharmaceuticals Business Overview
  10. 8.2.3 Zhejiang Supor Pharmaceuticals Levornidazole API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Supor Pharmaceuticals Levornidazole API Product Portfolio
  12. 8.2.5 Zhejiang Supor Pharmaceuticals Recent Developments
  13. 8.3 Nanjing Sanhome Pharmaceutical
  14. 8.3.1 Nanjing Sanhome Pharmaceutical Company Information
  15. 8.3.2 Nanjing Sanhome Pharmaceutical Business Overview
  16. 8.3.3 Nanjing Sanhome Pharmaceutical Levornidazole API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Sanhome Pharmaceutical Levornidazole API Product Portfolio
  18. 8.3.5 Nanjing Sanhome Pharmaceutical Recent Developments
  19. 8.4 Hunan Warrant Chiral Pharmaceutical
  20. 8.4.1 Hunan Warrant Chiral Pharmaceutical Company Information
  21. 8.4.2 Hunan Warrant Chiral Pharmaceutical Business Overview
  22. 8.4.3 Hunan Warrant Chiral Pharmaceutical Levornidazole API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Warrant Chiral Pharmaceutical Levornidazole API Product Portfolio
  24. 8.4.5 Hunan Warrant Chiral Pharmaceutical Recent Developments
9 North America
  1. 9.1 North America Levornidazole API Market Size by Type
  2. 9.1.1 North America Levornidazole API Revenue by Type (2021-2032)
  3. 9.1.2 North America Levornidazole API Sales by Type (2021-2032)
  4. 9.1.3 North America Levornidazole API Price by Type (2021-2032)
  5. 9.2 North America Levornidazole API Market Size by Application
  6. 9.2.1 North America Levornidazole API Revenue by Application (2021-2032)
  7. 9.2.2 North America Levornidazole API Sales by Application (2021-2032)
  8. 9.2.3 North America Levornidazole API Price by Application (2021-2032)
  9. 9.3 North America Levornidazole API Market Size by Country
  10. 9.3.1 North America Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Levornidazole API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Levornidazole API Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Levornidazole API Market Size by Type
  2. 10.1.1 Europe Levornidazole API Revenue by Type (2021-2032)
  3. 10.1.2 Europe Levornidazole API Sales by Type (2021-2032)
  4. 10.1.3 Europe Levornidazole API Price by Type (2021-2032)
  5. 10.2 Europe Levornidazole API Market Size by Application
  6. 10.2.1 Europe Levornidazole API Revenue by Application (2021-2032)
  7. 10.2.2 Europe Levornidazole API Sales by Application (2021-2032)
  8. 10.2.3 Europe Levornidazole API Price by Application (2021-2032)
  9. 10.3 Europe Levornidazole API Market Size by Country
  10. 10.3.1 Europe Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Levornidazole API Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Levornidazole API Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Levornidazole API Market Size by Type
  2. 11.1.1 China Levornidazole API Revenue by Type (2021-2032)
  3. 11.1.2 China Levornidazole API Sales by Type (2021-2032)
  4. 11.1.3 China Levornidazole API Price by Type (2021-2032)
  5. 11.2 China Levornidazole API Market Size by Application
  6. 11.2.1 China Levornidazole API Revenue by Application (2021-2032)
  7. 11.2.2 China Levornidazole API Sales by Application (2021-2032)
  8. 11.2.3 China Levornidazole API Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Levornidazole API Market Size by Type
  2. 12.1.1 Asia Levornidazole API Revenue by Type (2021-2032)
  3. 12.1.2 Asia Levornidazole API Sales by Type (2021-2032)
  4. 12.1.3 Asia Levornidazole API Price by Type (2021-2032)
  5. 12.2 Asia Levornidazole API Market Size by Application
  6. 12.2.1 Asia Levornidazole API Revenue by Application (2021-2032)
  7. 12.2.2 Asia Levornidazole API Sales by Application (2021-2032)
  8. 12.2.3 Asia Levornidazole API Price by Application (2021-2032)
  9. 12.3 Asia Levornidazole API Market Size by Country
  10. 12.3.1 Asia Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Levornidazole API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Levornidazole API Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Levornidazole API Market Size by Type
  2. 13.1.1 SAMEA Levornidazole API Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Levornidazole API Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Levornidazole API Price by Type (2021-2032)
  5. 13.2 SAMEA Levornidazole API Market Size by Application
  6. 13.2.1 SAMEA Levornidazole API Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Levornidazole API Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Levornidazole API Price by Application (2021-2032)
  9. 13.3 SAMEA Levornidazole API Market Size by Country
  10. 13.3.1 SAMEA Levornidazole API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Levornidazole API Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Levornidazole API Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Levornidazole API Value Chain Analysis
  2. 14.1.1 Levornidazole API Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Levornidazole API Production Mode & Process
  6. 14.2 Levornidazole API Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Levornidazole API Distributors
  9. 14.2.3 Levornidazole API Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst